Michael S. Simpson serves as Senior Vice President - Regulatory Affairs and Quality Assurance of the Company. Mr. Simpson was appointed to the position of Senior Vice President, Regulatory Affairs and Quality Assurance in December 2018. Prior to joining CryoLife, Mr. Simpson served as Vice President, Regulatory and Clinical Affairs for Becton Dickinson Urology and Critical Care (legacy Bard). Other prior significant roles included Vice President, Quality and Regulatory Affairs for Beckman Coulter Life Sciences, operating company of Danaher Corporation, Vice President, Quality, Regulatory, Clinical Affairs, and Compliance Officer for Exactech, Inc., and multiple leadership roles in product development and quality engineering at Novoste Corporation. Mr. Simpson received Bachelor and Master of Science degrees in Mechanical Engineering from the Georgia Institute of Technology in Atlanta.
As the Senior Vice President - Regulatory Affairs and Quality Assurance of Artivion Inc, the total compensation of Michael Simpson at Artivion Inc is $1,371,190. There are 3 executives at Artivion Inc getting paid more, with James Mackin having the highest compensation of $6,453,540.
Michael Simpson is 52, he's been the Senior Vice President - Regulatory Affairs and Quality Assurance of Artivion Inc since 2018. There are 18 older and 4 younger executives at Artivion Inc. The oldest executive at Artivion Inc is Ronald McCall, 83, who is the Presiding Independent Director.
Michael's mailing address filed with the SEC is 1655, Roberts Boulevard Northwest, Kennesaw, Cobb County, Georgia, 30144, United States of America.
Over the last 21 years, insiders at Artivion Inc have traded over $18,346,910 worth of Artivion Inc stock and bought 91,700 units worth $1,086,548 . The most active insiders traders include Steven G Anderson, Thomas F Ackerman és James P Mackin. On average, Artivion Inc executives and independent directors trade stock every 26 days with the average trade being worth of $211,842. The most recent stock trade was executed by Amy Horton on 8 December 2021, trading 2,500 units of CRY stock currently worth $46,425.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
Artivion Inc executives and other stock owners filed with the SEC include: